{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:24:43Z","timestamp":1793913883267,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573365"],"award-info":[{"award-number":["81573365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003667"],"award-info":[{"award-number":["82003667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biomaterials.2022.121720","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T17:49:44Z","timestamp":1659635384000},"page":"121720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Endoplasmic reticulum-targeted inhibition of CYP2E1 with vitamin E nanoemulsions alleviates hepatocyte oxidative stress and reverses alcoholic liver disease"],"prefix":"10.1016","volume":"288","author":[{"given":"Yingying","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengshi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningtao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7114-6299","authenticated-orcid":false,"given":"Jian","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2022.121720_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121720_bib2","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1053\/j.gastro.2016.02.043","article-title":"Alcoholic liver disease in asia, europe, and north America","volume":"150","author":"Liangpunsakul","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121720_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","article-title":"Global burden of alcoholic liver diseases","volume":"59","author":"Rehm","year":"2013","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121720_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.7326\/M20-7466","article-title":"Donald A Redelmeier Alcohol sales and alcohol-related emergencies during the COVID-19 pandemic","volume":"174","author":"Jonathan S Zipursky","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biomaterials.2022.121720_bib5","series-title":"Global Status Report on Alcohol and Health 2018","year":"2018"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121720_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8278(00)80420-1","article-title":"Alcoholic liver disease: new insights in pathogenesis lead to new treatments","volume":"32","author":"Lieber","year":"2000","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1465-3362.2009.00153.x","article-title":"Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis","volume":"29","author":"Rehm","year":"2010","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.biomaterials.2022.121720_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","article-title":"Treatment of alcohol use disorders in patients with alcoholic liver disease","volume":"65","author":"Addolorato","year":"2016","journal-title":"J. Hepatol."},{"issue":"17","key":"10.1016\/j.biomaterials.2022.121720_bib9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Allen zweben, COMBINE study Research group, combined pharmacotherapies and behavioral interventions for alcohol dependence","volume":"295","author":"Raymond F Anton","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121720_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax4043","article-title":"Advances in the science and treatment of alcohol use disorder","volume":"5","author":"K Witkiewitz","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121720_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut\u2013liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121720_bib12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121720_bib13","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"7783","key":"10.1016\/j.biomaterials.2022.121720_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2036.2003.01660.x","article-title":"Review article: nutritional therapy in alcoholic liver disease","volume":"18","author":"F Stickel","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.livres.2017.12.004","article-title":"Targeting the gut barrier for the treatment of alcoholic liver disease","volume":"1","author":"Zhou","year":"2017","journal-title":"Liver Res"},{"issue":"42","key":"10.1016\/j.biomaterials.2022.121720_bib17","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121720_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121720_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2011.134","article-title":"Alcoholic liver disease: pathogenesis and new targets for therapy","volume":"8","author":"Altamirano","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121720_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Kusum K Kharbanda Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Natalia A Osna","year":"2017","journal-title":"Alcohol Res"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121720_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2018.11.007","article-title":"Liver transplantation for alcoholic hepatitis","volume":"70","author":"Im","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121720_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrgastro.2013.247","article-title":"Liver transplantation for alcoholic liver disease","volume":"11","author":"Lucey","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121720_bib23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/gut.2005.090506","article-title":"Liver transplantation alcohol related liver disease: (deliberately) stirring a hornet's nest","volume":"55","author":"O'Grady","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib24","first-page":"277","article-title":"Alcohol, oxidative stress and free radical damage","volume":"27","author":"Defeng Wu","year":"2003","journal-title":"Alcohol Res. Health"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/0006-291X(70)90982-4","article-title":"Hepatic microsomal ethanol oxidizing system (MEOS): differentiation from alcohol dehydrogenase and NADPH oxidase","volume":"40","author":"Lieber","year":"1970","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.biomaterials.2022.121720_bib26","doi-asserted-by":"crossref","first-page":"17130","DOI":"10.1074\/jbc.M000957200","article-title":"Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane","volume":"275","author":"Neve","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.jbchem.a123619","article-title":"Genetic polymorphisms in the 5\u2019-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene","volume":"110","author":"S Hayashi","year":"1991","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121720_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0168-8278(01)00223-9","article-title":"Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase","volume":"36","author":"Carl","year":"2002","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121720_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.510230121","article-title":"Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol","volume":"23","author":"E Albano","year":"1996","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121720_bib30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc2191","article-title":"Molecular mechanisms of alcohol-mediated carcinogenesis","volume":"7","author":"Helmut K Seitz","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121720_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.22978","article-title":"Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121720_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121720_bib33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","article-title":"CYP2E1 and oxidative liver injury by alcohol","volume":"44","author":"Lu","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121720_bib34","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.freeradbiomed.2010.07.026","article-title":"Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice","volume":"49","author":"Lu","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121720_bib35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2008.10.020","article-title":"The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model","volume":"50","author":"Butura","year":"2009","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121720_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12638","article-title":"Induction of SIRT1 by melatonin improves alcohol-mediated oxidative liver injury by disrupting the CRBN-YY1-CYP2E1 signaling pathway","volume":"68","author":"Lee","year":"2020","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib37","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gutjnl-2021-324727","article-title":"Clomethiazole inhibits cytochrome P450 2E1 and improves alcoholic liver disease","volume":"71","author":"Hohmann","year":"2021","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121720_bib38","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1124\/dmd.116.070193","article-title":"Selective time- and NADPH-dependent inhibition of human CYP2E1 by Clomethiazole","volume":"44","author":"Stresser","year":"2016","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib39","first-page":"302","article-title":"Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by Chlormethiazole","volume":"224","author":"Gouillon","year":"2010","journal-title":"P SOC EXP BIOL MED"},{"key":"10.1016\/j.biomaterials.2022.121720_bib40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.smaim.2021.09.001","article-title":"Endoplasmic reticulum-targeting nanomedicines for cancer therapy","volume":"2","author":"Liu","year":"2021","journal-title":"Smart Materials in Medicine"},{"key":"10.1016\/j.biomaterials.2022.121720_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154","author":"Bottger","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2022.121720_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2020.11.054","article-title":"Pharmaceutical strategies for endoplasmic reticulum-targeting and their prospects of application","volume":"329","author":"Shi","year":"2021","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121720_bib43","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/hep.22470","article-title":"The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88","volume":"48","author":"Hritz","year":"2008","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121720_bib44","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.cmet.2019.10.010","article-title":"The crosstalk between hepatocytes, hepatic macrophages, and hepatic stellate cells facilitates alcoholic liver disease","volume":"30","author":"Kisseleva","year":"2019","journal-title":"Cell Metabol."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121720_bib45","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.4049\/jimmunol.168.6.2963","article-title":"Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice","volume":"168","author":"Uesugi","year":"2002","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121720_bib46","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2016.02.035","article-title":"Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes","volume":"150","author":"Nagy","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121720_bib47","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.22222","article-title":"Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice","volume":"47","author":"Lu","year":"2008","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121720_bib48","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/j.1530-0277.2007.00475.x","article-title":"Role of medium-chain triglycerides in the alcohol-mediated cytochrome P450 2E1 induction of mitochondria","volume":"31","author":"Lieber","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121720_bib49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1530-0277.2011.01673.x","article-title":"The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease","volume":"36","author":"Kirpich","year":"2012","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121720_bib50","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.SLA.0000048450.44868.B1","article-title":"Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin","volume":"237","author":"Hiroshi Kono","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.biomaterials.2022.121720_bib51","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0022-3565(25)13125-X","article-title":"Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease","volume":"277","author":"Nanji","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.biomaterials.2022.121720_bib52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fimmu.2018.00089","article-title":"The role of cytochromes P450 in infection","volume":"9","author":"Stavropoulou","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121720_bib53","first-page":"147","article-title":"Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD)","volume":"4","author":"Seitz","year":"2015","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121720_bib54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2017.11.006","article-title":"The bidirectional impacts of alcohol consumption and the metabolic syndrome: cofactors for progressive fatty liver disease","volume":"68","author":"Boyle","year":"2018","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121720_bib55","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/acer.13840","article-title":"The lieber-DeCarli diet-A flagship model for experimental alcoholic liver disease","volume":"42","author":"Guo","year":"2018","journal-title":"Alcohol Clin. Exp. Res."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122200360X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014296122200360X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:12:02Z","timestamp":1758906722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014296122200360X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":55,"alternative-id":["S014296122200360X"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121720","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoplasmic reticulum-targeted inhibition of CYP2E1 with vitamin E nanoemulsions alleviates hepatocyte oxidative stress and reverses alcoholic liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"121720"}}